Switch to:
More From Other Websites
Regeneron Pharmaceuticals’ Major Revenue Sources in 4Q15 Feb 12 2016
AstraZeneca’s Valuation Report Card: How Did It Score? Feb 12 2016
Sanofi Earnings Analysis: Q4, 2015 By the Numbers Feb 12 2016
Sanofi -- Moody's: Europe's pharma companies' earnings growth looking less rosy in 2016 Feb 10 2016
Sanofi Tops Q4 Earnings, Revenues Fall Y/Y, Gives 2016 View Feb 10 2016
[$$] How a Sanofi Diabetes Bet Went Wrong Feb 10 2016
Regeneron Q4 Earnings Miss Estimates Amid Slow Praluent Launch Feb 09 2016
[$$] Sanofi Is Forced to End Latest Diabetes Effort Feb 09 2016
Sanofi gets shot in the arm from dollar strength Feb 09 2016
[$$] Sanofi upbeat on prospects for heart drug despite slow start in US Feb 09 2016
Regeneron: Get Used to Disappointment Feb 09 2016
Sanofi reports flat 2015 earnings Feb 09 2016
Sanofi reports flat 2015 earnings Feb 09 2016
Sanofi's Stock Dips Lower Following Q4 Print Feb 09 2016
Sanofi Delivered 2015 Business EPS up 8.5% on a Reported Basis and Stable at Constant Exchange Rates... Feb 09 2016
[$$] Regeneron Reports Slowing Sales Growth for Key Eye Drug Feb 09 2016
​Sanofi Genzyme revenues grow 20% in 2015 to top $4B Feb 09 2016
Sanofi gets shot in the arm from dollar strength Feb 09 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK